Management of Cardiovascular Risk Associated with Insulin Resistance, Diabetes, and the Metabolic Syndrome

被引:2
作者
Mehta, Adi [1 ]
机构
[1] Cleveland Clin, Dept Diabet Endocrinol & Metab, Cleveland, OH 44195 USA
关键词
metabolic syndrome; dyslipidemia; insulin resistance; diabetes; CORONARY-HEART-DISEASE; IMPAIRED FASTING GLUCOSE; GLYCEMIC CONTROL; ATHEROGENIC DYSLIPIDEMIA; COMBINED HYPERLIPIDEMIA; MYOCARDIAL-INFARCTION; SECONDARY PREVENTION; PLUS FENOFIBRATE; LDL CHOLESTEROL; DRUG-TREATMENT;
D O I
10.3810/pgm.2010.05.2143
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The metabolic syndrome is a cluster of symptoms that function as risk factors for cardiovascular disease (CVD), and its key components-diabetes, dyslipidemia, and hypertension-form a lethal combination. The incidence of obesity and other components of the metabolic syndrome is now at epidemic proportions, and current lifestyle trends suggest that it will continue to increase worldwide. In order to avert a major health crisis, physicians must take immediate steps to recognize and treat the metabolic syndrome and its components. Early diagnosis and therapeutic lifestyle changes should go hand-in-hand with individual and composite therapy for metabolic syndrome components to reduce CVD risk in affected individuals. This review provides a comprehensive overview of the diagnosis and treatment of the metabolic syndrome with a particular emphasis on reducing CVD risk.
引用
收藏
页码:61 / 70
页数:10
相关论文
共 67 条
[1]  
*ACCORD STUD GROUP, N ENGL J MED
[2]   Acute coronary syndromes and diabetes: is intensive lipid lowering beneficial? Results of the PROVE IT-TIMI 22 trial [J].
Ahmed, Shaheeda ;
Cannon, Christopher P. ;
Murphy, Sabina A. ;
Braunwald, Eugene .
EUROPEAN HEART JOURNAL, 2006, 27 (19) :2323-2329
[3]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[4]  
2-S
[5]   Standards of medical care in diabetes 2008 [J].
不详 .
DIABETES CARE, 2008, 31 :S12-S54
[6]  
Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198
[7]  
[Anonymous], 1975, JAMA-J AM MED ASSOC, V231, P360
[8]  
[Anonymous], 1978, Atherosclerosis, V30, P239
[9]  
[Anonymous], 2006, DIAB ATL
[10]  
[Anonymous], 1996, 3 NAT HLTH NUTR EX S